A Trial of Sugemalimab and Chemotherapy in Unresectable Stage III NSCLC

Clinical trial NCT05940532 · RECRUITING

Trial details

NCT number: NCT05940532
Sponsor: Hunan Cancer Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2023-06-14
Primary completion: 2025-01-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.